Early Parenteral Nutrition in Critically Ill Patients With Short-term Relative Contraindications to Early Enteral Nutrition
Top Cited Papers
- 22 May 2013
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 309 (20), 2130-2138
- https://doi.org/10.1001/jama.2013.5124
Abstract
Importance Systematic reviews suggest adult patients in intensive care units (ICUs) with relative contraindications to early enteral nutrition (EN) may benefit from parenteral nutrition (PN) provided within 24 hours of ICU admission. Objective To determine whether providing early PN to critically ill adults with relative contraindications to early EN alters outcomes. Design, Setting, and Participants Multicenter, randomized, single-blind clinical trial conducted between October 2006 and June 2011 in ICUs of 31 community and tertiary hospitals in Australia and New Zealand. Participants were critically ill adults with relative contraindications to early EN who were expected to remain in the ICU longer than 2 days. Interventions Random allocation to pragmatic standard care or early PN. Main Outcomes and Measures Day-60 mortality; quality of life, infections, and body composition. Results A total of 1372 patients were randomized (686 to standard care, 686 to early PN). Of 682 patients receiving standard care, 199 patients (29.2%) initially commenced EN, 186 patients (27.3%) initially commenced PN, and 278 patients (40.8%) remained unfed. Time to EN or PN in patients receiving standard care was 2.8 days (95% CI, 2.3 to 3.4). Patients receiving early PN commenced PN a mean of 44 minutes after enrollment (95% CI, 36 to 55). Day-60 mortality did not differ significantly (22.8% for standard care vs 21.5% for early PN; risk difference, −1.26%; 95% CI, −6.6 to 4.1; P = .60). Early PN patients rated day-60 quality of life (RAND-36 General Health Status) statistically, but not clinically meaningfully, higher (45.5 for standard care vs 49.8 for early PN; mean difference, 4.3; 95% CI, 0.95 to 7.58; P = .01). Early PN patients required fewer days of invasive ventilation (7.73 vs 7.26 days per 10 patient × ICU days, risk difference, −0.47; 95% CI, −0.82 to −0.11; P = .01) and, based on Subjective Global Assessment, experienced less muscle wasting (0.43 vs 0.27 score increase per week; mean difference, −0.16; 95% CI, −0.28 to −0.038; P = .01) and fat loss (0.44 vs 0.31 score increase per week; mean difference, −0.13; 95% CI, −0.25 to −0.01; P = .04). Conclusions and Relevance The provision of early PN to critically ill adults with relative contraindications to early EN, compared with standard care, did not result in a difference in day-60 mortality. The early PN strategy resulted in significantly fewer days of invasive ventilation but not significantly shorter ICU or hospital stays. Trial Registration anzctr.org.au Identifier: ACTRN012605000704695Keywords
This publication has 26 references indexed in Scilit:
- Early versus Late Parenteral Nutrition in Critically Ill AdultsThe New England Journal of Medicine, 2011
- Death by total parenteral nutrition: The saga continues*Critical Care Medicine, 2011
- Impact of early parenteral nutrition completing enteral nutrition in adult critically ill patients (EPaNIC trial): a study protocol and statistical analysis plan for a randomized controlled trialTrials, 2011
- A systematic review of techniques and interventions for improving adherence to inclusion and exclusion criteria during enrolment into randomised controlled trialsTrials, 2010
- ESPEN Guidelines on Parenteral Nutrition: Intensive careClinical Nutrition, 2009
- If You Don't Connect the Dots, You May Not See the Whole Picture!Journal of Parenteral and Enteral Nutrition, 2008
- Parenteral vs. enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principleIntensive Care Medicine, 2004
- Early developments and clinical applications of total parenteral nutritionJournal of Parenteral and Enteral Nutrition, 2003
- Allocation concealment in randomised trials: defending against decipheringThe Lancet, 2002
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960